Skip to main content
Chinese Medical Journal logoLink to Chinese Medical Journal
letter
. 2020 Apr 16;133(10):1239–1241. doi: 10.1097/CM9.0000000000000771

Reference intervals for steroid hormones in healthy 6- to 15-year-old girls based on liquid chromatography-tandem mass spectrometry in China

Jia-Li Wang 1,2, Bing-Yan Cao 1,2, Chun-Xiu Gong 1,2, Di Wu 1,2, Jia-Jia Chen 1,2, Li-Ya Wei 1,2
Editor: Li-Min Chen
PMCID: PMC7249713  PMID: 32433057

To the Editor: Adrenal and gonadal function can be evaluated by analyzing steroid hormone levels in different age groups, especially adolescent girls. Liquid chromatography-tandem mass spectrometry (LC-MS/MS or high-performance LC [HPLC]-MS/MS) offers a combination of the physical separation capabilities of HPLC and the mass analysis capabilities of tandem MS, which improves sensitivity and specificity in measuring steroid hormone levels.[1,2] This method is more sensitive, effective, specific, and homogenous than other methods for analyzing children's steroid hormone levels in the clinic. Studies on the reference intervals of steroid sex hormones have more commonly performed with Caucasian subjects than with Chinese subjects.[3] LC-MS/MS-based reference intervals for steroid hormones in China, especially for healthy girls, have not yet been reported. With LC-MS/MS becoming increasingly common, the establishment of reference intervals is growing more urgent. Here, we define appropriate reference ranges for pregnenolone, 17α-hydroxyprogesterone, corticosterone, dehydroepiandrosterone, androstenedione, and free testosterone.

This study was approved by the Ethics Committee of Beijing Children's Hospital of Capital Medical University, and written informed consent was obtained from the participants’ guardians.

A total of 981 girls (aged 6–15 years) were selected from middle and elementary schools in Shunyi, Beijing using the cluster sampling method. A total of 265 participants with severe disease, medication use or a body mass index at or above the 85th percentile for children of the same age and sex were excluded. A total of 716 healthy girls were included. No malnourished children were included. The girls were allocated to four age groups, namely, 6 to <9 years, 9 to <11 years, 11 to <13 years, and 13 to 15 years. Tanner stages of breast (B) and pubic hair (PH) development were assessed by trained pediatricians using on-the-spot interviews.

Serum samples were collected in a fasting state (8–12 h) between 7:30 and 8:30 am. After preparation by centrifugation (3000 r/min, 15 min), serum samples were kept frozen at −80°C until use. Free testosterone in serum was measured with a chemiluminescence immunoassay (CLIA) using a Maglumi® 2000 automatic immunoassay analyzer (New Industries Biomedical Engineering Co., Ltd., Shenzhen, China). The intra- and inter-assay coefficients of variation (CVs) for free testosterone were <10%, and the lower limit of detection for free testosterone was 0.5 pg/mL. The serum concentrations of pregnenolone, 17α-hydroxyprogesterone, corticosterone, dehydroepiandrosterone, and androstenedione were measured by LC-MS/MS using an Agilent 1200 Series HPLC system (Agilent Technologies Inc., Santa Clara, CA, USA) and an AB Sciex API5000 tandem mass spectrometer (AB Sciex Pte. Ltd, Foster City, CA, USA). The corresponding serum limit of quantification values and inter-assay CVs were determined and are listed in Supplementary Table 1.

All statistical analyses were carried out using SPSS version 23.0 (SPSS Inc., Chicago, IL, USA). Due to the non-normal distribution, the 2.5th, 25th, 50th, 75th, and 97.5th percentiles were calculated for each group. Interclass variance was analyzed with the Kruskal-Wallis test. Differences with P values <0.05 were considered statistically significant.

Two outliers were eliminated according to CLSI C28-A3, and the median age of 714 healthy girls was 10.6 years with an interquartile range of 8.8 to 13.2 years.

The percentages for Tanner stages of B and PH development in each age group of healthy girls are shown in Supplementary Figure 1. The proportion of B2 and above was 6.84% from age 6 to <9 years, 64.10% from age 9 to <11 years, 93.75% from age 11 to <13 years, and 100% from age 13 to 15 years. The proportion of PH2 and above was 0 from age 6 to <9 years, 10.26% from age 9 to <11 years, 64.06% from age 11 to <13 years, and 100% from age 13 to 15 years.

Tables 1 and 2 provide the data for the serum concentrations of six steroid hormones in each age group and B stage. We could not measure the hormone levels in all of the girls due to the limited volume of serum samples, and thus, the “n” values differ. The differences in pregnenolone, 17α-hydroxyprogesterone, dehydroepiandrosterone, androstenedione, and free testosterone among the age groups from 6 to 15 years were significant, but there was no significant difference in corticosterone among the age groups (χ2 = 3, P = 0.22). The interval of corticosterone from 6 to 15 years is 0.30 to 8.99 μg/L, and the median (interquartile range) is 2.41 (0.80–2.55) μg/L. The age-associated changes in the levels of the six hormones in healthy girls are shown in Figure 1. The concentrations of pregnenolone and 17α-hydroxyprogesterone remained stable with age among girls younger than 9 years and started to increase thereafter. The levels of dehydroepiandrosterone, androstenedione and free testosterone continuously increased from 6 to 15 years old, while that of corticosterone did not change significantly with age.

Table 1.

Reference intervals for the concentrations of six steroid hormones in each age group.

graphic file with name cm9-133-1239-g001.jpg

Table 2.

Reference intervals for the concentrations of six steroid hormones during different Tanner stages of breast development.

graphic file with name cm9-133-1239-g002.jpg

Figure 1.

Figure 1

Changes in the concentrations of six hormones with age in healthy girls.

In this study, the changes in the six steroid sex hormones with age and puberty in healthy girls from 6 to 15 years old were consistent with the development of the adrenal glands and gonads. The serum levels of pregnenolone and 17α-hydroxyprogesterone showed no significant changes from adrenarche (6−8 years old) to 9 years old, but after 10 years of age, they increased with age as a result of the adrenal gland response to adrenocorticotropic hormone (ACTH). This is because the Δ5 pathway predominates, while the Δ4 pathway does not respond to ACTH well at adrenarche. At the same time, 3β-hydroxysteroid dehydrogenase (3β-HSD) showed very low activity. The level of dehydroepiandrosterone, as the main marker of adrenarche, increased with age beginning at 6 years and continued to increase throughout puberty. This is the result of the development and differentiation of the adrenal gland, as well as changes in steroid hormone syntheses.[4] The serum levels of androstenedione and free testosterone increase with age because the number of 3β-HSD and Cyt-b5 double-positive hybrid cells increases with the growth of the adrenal cortex,[5] and the production of androstenedione in the ovary also increases with the initiation of puberty. The serum level of free testosterone increases with age as a result of the increase in the substrate level and 17β-HSD activity. The level of corticosterone, as a precursor of aldosterone, did not change with age.

We provide reference intervals for steroid sex hormones in 6- to 15-year-old healthy female children based on the LC-MS/MS method. The levels of certain hormones change with age and pubertal status. These references are valuable for the diagnosis and treatment of pediatric adrenal and gonadal diseases, as well as for future research on adrenarche and gonadal initiation and progression.

Funding

This study was supported by a grant from the National Key Research and Development Program of China (No. 2016YFC0901505); Beijing Municipal Administration of Hospital Clinical Medicine Development of Special Funding Support (No. ZYLX201821); The series research on the pediatric gonadal diseases those affecting the fertility in adulthood (No. XTYB201808).

Conflicts of interest

None.

Supplementary Material

Supplemental Digital Content
cm9-133-1239-s001.docx (176.6KB, docx)

Footnotes

How to cite this article: Wang JL, Cao BY, Gong CX, Wu D, Chen JJ, Wei LY. Reference intervals for steroid hormones in healthy 6- to 15-year-old girls based on liquid chromatography-tandem mass spectrometry in China. Chin Med J 2020;133:1239–1241. doi: 10.1097/CM9.0000000000000771

References

  • 1.Bae YJ, Zeidler R, Baber R, Vogel M, Wirkner K, Loeffler M, et al. Reference intervals of nine steroid hormones over the life-span analyzed by LC-MS/MS: effect of age, gender, puberty, and oral contraceptives. J Steroid Biochem Mol Biol 2019; 193:105409.doi: 10.1016/j.jsbmb.2019.105409. [DOI] [PubMed] [Google Scholar]
  • 2.Cao BY, Gong CX, Wu D, Liang XJ, Li WJ, Liu M, et al. Liquid chromatography-tandem mass spectrometry based characterization of steroid hormone profiles in healthy 6 to 14-year-old male children. Chin Med J 2018; 131:862–866. doi: 10.4103/0366-6999.228238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Karbasy K, Ariadne P, Gaglione S, Nieuwesteeg M, Adeli K. Advances in pediatric reference intervals for biochemical markers: establishment of the caliper database in healthy children and adolescent. J Med Biochem 2015; 34:23–30. doi: 10.2478/jomb-2014-0063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Xing Y, Lerario AM, Rainey W, Hammer GD. Development of adrenal cortex zonation. Endocrinol Metab Clin North Am 2015; 44:243–274. doi: 10.1016/j.ecl.2015.02.00. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Nakamura Y, Fujishima F, Hui XG, Felizola SJ, Shibahara Y, Akahira J, et al. 3betaHSD and CYB5A double positive adrenocortical cells during adrenal development/aging. Endocr Res 2015; 40:8–13. doi: 10.3109/07435800.2014.895377. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Digital Content
cm9-133-1239-s001.docx (176.6KB, docx)

Articles from Chinese Medical Journal are provided here courtesy of Wolters Kluwer Health

RESOURCES